Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection

Guanpingshen Luo, Lin Lin, Ashraf S. Ibrahim, Beverlie Baquir, Paul Pantapalangkoor, Robert A. Bonomo, Yohei Doi, Mark D. Adams, Thomas A. Russo, Brad Spellberg

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Extreme-drug-resistant (XDR) Acinetobacter baumannii is a rapidly emerging pathogen causing infections with unacceptably high mortality rates due to inadequate available treatment. New methods to prevent and treat such infections are a critical unmet medical need. To conduct a rational vaccine discovery program, OmpA was identified as the primary target of humoral immune response after intravenous infection by A. baumannii in mice. OmpA was >99% conserved at the amino acid level across clinical isolates harvested between 1951 and 2009 from cerebrospinal fluid, blood, lung, and wound infections, including carbapenem-resistant isolates, and was ≥89% conserved among other sequenced strains, but had minimal homology to the human proteome. Vaccination of diabetic mice with recombinant OmpA (rOmpA) with aluminum hydroxide adjuvant markedly improved survival and reduced tissue bacterial burden in mice infected intravenously. Vaccination induced high titers of anti-OmpA antibodies, the levels of which correlated with survival in mice. Passive transfer with immune sera recapitulated protection. Immune sera did not enhance complement-mediated killing but did enhance opsonophagocytic killing of A. baumannii. These results define active and passive immunization strategies to prevent and treat highly lethal, XDR A. baumannii infections.

Original languageEnglish
Article numbere29446
JournalPloS one
Volume7
Issue number1
DOIs
Publication statusPublished - 10-01-2012

Fingerprint

Acinetobacter Infections
Acinetobacter baumannii
Immunization
Passive Immunization
Immune Sera
immunization
Vaccination
Cerebrospinal fluid
Aluminum Hydroxide
drugs
Carbapenems
Pathogens
Proteome
infection
Pharmaceutical Preparations
mice
Blood
Vaccines
Infection
antiserum

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Luo, G., Lin, L., Ibrahim, A. S., Baquir, B., Pantapalangkoor, P., Bonomo, R. A., ... Spellberg, B. (2012). Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PloS one, 7(1), [e29446]. https://doi.org/10.1371/journal.pone.0029446
Luo, Guanpingshen ; Lin, Lin ; Ibrahim, Ashraf S. ; Baquir, Beverlie ; Pantapalangkoor, Paul ; Bonomo, Robert A. ; Doi, Yohei ; Adams, Mark D. ; Russo, Thomas A. ; Spellberg, Brad. / Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. In: PloS one. 2012 ; Vol. 7, No. 1.
@article{ff356fea0cba4bc795b0b753215983db,
title = "Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection",
abstract = "Extreme-drug-resistant (XDR) Acinetobacter baumannii is a rapidly emerging pathogen causing infections with unacceptably high mortality rates due to inadequate available treatment. New methods to prevent and treat such infections are a critical unmet medical need. To conduct a rational vaccine discovery program, OmpA was identified as the primary target of humoral immune response after intravenous infection by A. baumannii in mice. OmpA was >99{\%} conserved at the amino acid level across clinical isolates harvested between 1951 and 2009 from cerebrospinal fluid, blood, lung, and wound infections, including carbapenem-resistant isolates, and was ≥89{\%} conserved among other sequenced strains, but had minimal homology to the human proteome. Vaccination of diabetic mice with recombinant OmpA (rOmpA) with aluminum hydroxide adjuvant markedly improved survival and reduced tissue bacterial burden in mice infected intravenously. Vaccination induced high titers of anti-OmpA antibodies, the levels of which correlated with survival in mice. Passive transfer with immune sera recapitulated protection. Immune sera did not enhance complement-mediated killing but did enhance opsonophagocytic killing of A. baumannii. These results define active and passive immunization strategies to prevent and treat highly lethal, XDR A. baumannii infections.",
author = "Guanpingshen Luo and Lin Lin and Ibrahim, {Ashraf S.} and Beverlie Baquir and Paul Pantapalangkoor and Bonomo, {Robert A.} and Yohei Doi and Adams, {Mark D.} and Russo, {Thomas A.} and Brad Spellberg",
year = "2012",
month = "1",
day = "10",
doi = "10.1371/journal.pone.0029446",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

Luo, G, Lin, L, Ibrahim, AS, Baquir, B, Pantapalangkoor, P, Bonomo, RA, Doi, Y, Adams, MD, Russo, TA & Spellberg, B 2012, 'Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection', PloS one, vol. 7, no. 1, e29446. https://doi.org/10.1371/journal.pone.0029446

Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. / Luo, Guanpingshen; Lin, Lin; Ibrahim, Ashraf S.; Baquir, Beverlie; Pantapalangkoor, Paul; Bonomo, Robert A.; Doi, Yohei; Adams, Mark D.; Russo, Thomas A.; Spellberg, Brad.

In: PloS one, Vol. 7, No. 1, e29446, 10.01.2012.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection

AU - Luo, Guanpingshen

AU - Lin, Lin

AU - Ibrahim, Ashraf S.

AU - Baquir, Beverlie

AU - Pantapalangkoor, Paul

AU - Bonomo, Robert A.

AU - Doi, Yohei

AU - Adams, Mark D.

AU - Russo, Thomas A.

AU - Spellberg, Brad

PY - 2012/1/10

Y1 - 2012/1/10

N2 - Extreme-drug-resistant (XDR) Acinetobacter baumannii is a rapidly emerging pathogen causing infections with unacceptably high mortality rates due to inadequate available treatment. New methods to prevent and treat such infections are a critical unmet medical need. To conduct a rational vaccine discovery program, OmpA was identified as the primary target of humoral immune response after intravenous infection by A. baumannii in mice. OmpA was >99% conserved at the amino acid level across clinical isolates harvested between 1951 and 2009 from cerebrospinal fluid, blood, lung, and wound infections, including carbapenem-resistant isolates, and was ≥89% conserved among other sequenced strains, but had minimal homology to the human proteome. Vaccination of diabetic mice with recombinant OmpA (rOmpA) with aluminum hydroxide adjuvant markedly improved survival and reduced tissue bacterial burden in mice infected intravenously. Vaccination induced high titers of anti-OmpA antibodies, the levels of which correlated with survival in mice. Passive transfer with immune sera recapitulated protection. Immune sera did not enhance complement-mediated killing but did enhance opsonophagocytic killing of A. baumannii. These results define active and passive immunization strategies to prevent and treat highly lethal, XDR A. baumannii infections.

AB - Extreme-drug-resistant (XDR) Acinetobacter baumannii is a rapidly emerging pathogen causing infections with unacceptably high mortality rates due to inadequate available treatment. New methods to prevent and treat such infections are a critical unmet medical need. To conduct a rational vaccine discovery program, OmpA was identified as the primary target of humoral immune response after intravenous infection by A. baumannii in mice. OmpA was >99% conserved at the amino acid level across clinical isolates harvested between 1951 and 2009 from cerebrospinal fluid, blood, lung, and wound infections, including carbapenem-resistant isolates, and was ≥89% conserved among other sequenced strains, but had minimal homology to the human proteome. Vaccination of diabetic mice with recombinant OmpA (rOmpA) with aluminum hydroxide adjuvant markedly improved survival and reduced tissue bacterial burden in mice infected intravenously. Vaccination induced high titers of anti-OmpA antibodies, the levels of which correlated with survival in mice. Passive transfer with immune sera recapitulated protection. Immune sera did not enhance complement-mediated killing but did enhance opsonophagocytic killing of A. baumannii. These results define active and passive immunization strategies to prevent and treat highly lethal, XDR A. baumannii infections.

UR - http://www.scopus.com/inward/record.url?scp=84855588250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855588250&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0029446

DO - 10.1371/journal.pone.0029446

M3 - Article

C2 - 22253723

AN - SCOPUS:84855588250

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 1

M1 - e29446

ER -